Question 1

Am I eligible for this trial based on my current diabetes treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes clinical trial (NCT01167881). Contact the study team or your healthcare provider for specific answers.

Question 2

How does empagliflozin compare to my current diabetes medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes clinical trial (NCT01167881). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of empagliflozin?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes clinical trial (NCT01167881). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes clinical trial (NCT01167881). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the trial in terms of tests and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes clinical trial (NCT01167881). Contact the study team or your healthcare provider for specific answers.

Question 6

How will this trial fit into my overall diabetes management plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes clinical trial (NCT01167881). Contact the study team or your healthcare provider for specific answers.

What this study is about